André P Fay

Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final totale...

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final totale overleving re...

Durvalumab met of zonder tremelimumab versus chemotherapie bij urotheelcarcinoom: DANUBE fase III